» Articles » PMID: 26181604

Pancreatic Ductal Adenocarcinoma Concomitant with Intraductal Papillary Mucinous Neoplasm: a Report of 8 Cases

Overview
Specialty Gastroenterology
Date 2015 Jul 17
PMID 26181604
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Branch-duct intraductal papillary mucinous neoplasm (BD-IPMN) is recognized as a risk factor for pancreatic ductal adenocarcinoma (PDAC) that is unrelated to the malignant transformation of IPMN. We experienced 8 cases of resected PDAC concomitant with IPMN from March 1988 to December 2012, and 7 patients had >2 risk factors, including IPMN, for pancreatic cancer. Seven of the IPMNs were <30 mm in size, while none had mural nodules. Four cases of PDAC were detected during the follow-up period for BD-IPMN. Neither magnetic resonance cholangiopancreaticography nor contrast-enhanced computed tomography performed 5 months prior to the detection of PDAC resulted in its early detection in 2 cases. The clinical features of the 8 cases indicate that particular attention is required for patients with >1 risk factor, in addition to IPMN, for pancreatic cancer. A shorter interval of surveillance than that suggested by the international consensus guidelines 2012 is required, even if the IPMNs are small, for the early detection of PDAC.

Citing Articles

Propensity Score Matching Analysis of the Safety of Completion Total Pancreatectomy for Remnant Pancreatic Tumors Versus that of Initial Total Pancreatectomy for Primary Pancreatic Tumors.

Kanemitsu E, Masui T, Nagai K, Anazawa T, Kasai Y, Yogo A Ann Surg Oncol. 2023; 30(7):4392-4406.

PMID: 36933081 DOI: 10.1245/s10434-023-13309-6.


Pancreatic Ductal Adenocarcinoma Concomitant with Main Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Case Report.

Yonamine K, Koshita S, Kanno Y, Ogawa T, Kusunose H, Sakai T Am J Case Rep. 2021; 22:e932565.

PMID: 34473678 PMC: 8422565. DOI: 10.12659/AJCR.932565.


Independent predictors of secondary invasive pancreatic remnant tumors after initial resection of an intraductal papillary mucinous neoplasm: a nationwide large-scale survey in Japan.

Takigawa Y, Kitago M, Matsui J Surg Today. 2020; 50(12):1672-1680.

PMID: 32661567 PMC: 7677271. DOI: 10.1007/s00595-020-02074-8.

References
1.
Furukawa H, Okada S, Saisho H, Ariyama J, Karasawa E, Nakaizumi A . Clinicopathologic features of small pancreatic adenocarcinoma. A collective study. Cancer. 1996; 78(5):986-90. DOI: 10.1002/(SICI)1097-0142(19960901)78:5<986::AID-CNCR7>3.0.CO;2-A. View

2.
Shimosegawa T, Kataoka K, Kamisawa T, Miyakawa H, Ohara H, Ito T . The revised Japanese clinical diagnostic criteria for chronic pancreatitis. J Gastroenterol. 2010; 45(6):584-91. DOI: 10.1007/s00535-010-0242-4. View

3.
Muller M, Meyenberger C, Bertschinger P, Schaer R, Marincek B . Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology. 1994; 190(3):745-51. DOI: 10.1148/radiology.190.3.8115622. View

4.
Ingkakul T, Sadakari Y, Ienaga J, Satoh N, Takahata S, Tanaka M . Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg. 2009; 251(1):70-5. DOI: 10.1097/SLA.0b013e3181c5ddc3. View

5.
Yamaguchi K, Kanemitsu S, Hatori T, Maguchi H, Shimizu Y, Tada M . Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas. 2011; 40(4):571-80. DOI: 10.1097/MPA.0b013e318215010c. View